» Articles » PMID: 37233480

Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2023 May 26
PMID 37233480
Authors
Affiliations
Soon will be listed here.
Abstract

α4/6-conotoxin TxID, which was identified from , simultaneously blocks rat (r) α3β4 and rα6/α3β4 nicotinic acetylcholine receptors (nAChRs) with IC values of 3.6 nM and 33.9 nM, respectively. In order to identify the effects of loop2 size on the potency of TxID, alanine (Ala) insertion and truncation mutants were designed and synthesized in this study. An electrophysiological assay was used to evaluate the activity of TxID and its loop2-modified mutants. The results showed that the inhibition of 4/7-subfamily mutants [+9A]TxID, [+10A]TxID, [+14A]TxID, and all the 4/5-subfamily mutants against rα3β4 and rα6/α3β4 nAChRs decreased. Overall, ala-insertion or truncation of the 9th, 10th, and 11th amino acid results in a loss of inhibition and the truncation of loop2 has more obvious impacts on its functions. Our findings have strengthened the understanding of α-conotoxin, provided guidance for further modifications, and offered a perspective for future studies on the molecular mechanism of the interaction between α-conotoxins and nAChRs.

Citing Articles

Single Amino Acid Substitution in Loop1 Switches the Selectivity of α-Conotoxin RegIIA towards the α7 Nicotinic Acetylcholine Receptor.

Yu J, Xie J, Ma Y, Wei P, Zhang P, Tang Z Mar Drugs. 2024; 22(9).

PMID: 39330271 PMC: 11433573. DOI: 10.3390/md22090390.


Chemical Synthesis and Insecticidal Activity Research Based on α-Conotoxins.

Lin C, Qin H, Liao Y, Chen J, Gao B Molecules. 2024; 29(12).

PMID: 38930912 PMC: 11206848. DOI: 10.3390/molecules29122846.

References
1.
Olivera B, Quik M, Vincler M, McIntosh J . Subtype-selective conopeptides targeted to nicotinic receptors: Concerted discovery and biomedical applications. Channels (Austin). 2008; 2(2):143-52. DOI: 10.4161/chan.2.2.6276. View

2.
Wieskopf J, Mathur J, Limapichat W, Post M, Al-Qazzaz M, Sorge R . The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors. Sci Transl Med. 2015; 7(287):287ra72. PMC: 5018401. DOI: 10.1126/scitranslmed.3009986. View

3.
Ma Q, Tae H, Wu G, Jiang T, Yu R . Exploring the Relationship between Nicotinic Acetylcholine Receptor Ligand Size, Efficiency, Efficacy, and C-Loop Opening. J Chem Inf Model. 2017; 57(8):1947-1956. DOI: 10.1021/acs.jcim.7b00152. View

4.
Chi S, Kim D, Olivera B, McIntosh J, Han K . Solution conformation of a neuronal nicotinic acetylcholine receptor antagonist alpha-conotoxin OmIA that discriminates alpha3 vs. alpha6 nAChR subtypes. Biochem Biophys Res Commun. 2006; 345(1):248-54. DOI: 10.1016/j.bbrc.2006.04.099. View

5.
Craig A, Bandyopadhyay P, Olivera B . Post-translationally modified neuropeptides from Conus venoms. Eur J Biochem. 1999; 264(2):271-5. DOI: 10.1046/j.1432-1327.1999.00624.x. View